Download FREE Report Sample
Download Free sampleProthrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Human Prothrombin Complex Market contains market size and forecasts of Human Prothrombin Complex in global, including the following market information:
Global Human Prothrombin Complex Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Prothrombin Complex Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Prothrombin Complex companies in 2021 (%)
The global Human Prothrombin Complex market was valued at 1622.7 million in 2021 and is projected to reach US$ 3431.5 million by 2028, at a CAGR of 11.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
500 IU/Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Prothrombin Complex include Takeda, CSL, Grifols, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Prothrombin Complex manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Prothrombin Complex Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Prothrombin Complex Market Segment Percentages, by Type, 2021 (%)
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Global Human Prothrombin Complex Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Prothrombin Complex Market Segment Percentages, by Application, 2021 (%)
Hemophilia B
Vitamin K Deficiency
Others
Global Human Prothrombin Complex Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Prothrombin Complex Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Prothrombin Complex revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Prothrombin Complex revenues share in global market, 2021 (%)
Key companies Human Prothrombin Complex sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Prothrombin Complex sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
